flow trial semaglutide kidney outcomes 2024 nejm hazard ratio ❇️Patients with obesity, type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. This study, the now published, evaluated treatment with (# Effects of semaglutide with and

Phase 2 Obesity Trial Jastreboff et al., New England Journal of Medicine (2023) Jastreboff and colleagues conducted a phase 2, double-blind, randomized, placebo-controlled trial of retatrutide in adults with obesity

Comprehensive health evaluation: A qualified provider will evaluate your full medical history, current medications, and existing health conditions before prescribing

Delivered as an injectable solution, Ozempic (0.25mg, 0.5mg and 1mg) is a GLP-1 receptor agonist that improves #glycaemic control

doi: 10.1016/j.jphs.2017.11.004 82 LiX.HensonM

People with specific thyroid cancer histories are advised against these medications as a safety measure